May 11, 2026

Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)

WALTHAM, Mass., May 11, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative,...

Read More
Demyelination of Neurons in Demyelinating Diseases Impact of Mye
April 22, 2026

Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting

WALTHAM, Mass., April 22, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative,...

Read More
Clive Wang
March 26, 2026

Sironax Appoints Clive Wang to Board of Directors

WALTHAM, Mass., March 26, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative,...

Read More
Sironax Announces Upcoming Poster Presentation on NAMPT Activation
March 20, 2026

Sironax Announces Upcoming Poster Presentation on NAMPT Activation

WALTHAM, Mass., March 20, 2026 – Sironax, a global clinical-stage biotechnology company developing transformative therapies for...

Read More
Employees Share Their Pride in Accomplishments at Sironax
February 6, 2026

Employees Share Their Pride in Accomplishments at Sironax

...

Read More
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
November 6, 2025

Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025

WALTHAM, Mass., Nov. 6, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...

Read More
Neuron Synapse
October 22, 2025

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development

WALTHAM, Mass., Oct. 22, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...

Read More
Endpoints 11
September 19, 2025

Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups

WALTHAM, Mass., Sept. 19, 2025 – Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative...

Read More
July 10, 2025

Comments from Dr. Shefali Agarwal, President and CEO, on Agreement with Novartis

...

Read More